Factors associated with immunotherapy respond and survival in advanced non-small cell lung cancer patients

Objectives: This study aimed to explore factors associated with immunotherapy respond and survival in advanced non-small cell lung cancer (aNSCLC) patients treated with immune checkpoint inhibitors (ICIs). Methods: A total of 101 patients with aNSCLC receiving ICIs were included. The association bet...

Full description

Bibliographic Details
Main Authors: Yahua Wu, Haishan Wu, Mingqiang Lin, Tianxiu Liu, Jiancheng Li
Format: Article
Language:English
Published: Elsevier 2022-01-01
Series:Translational Oncology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S193652332100259X